vs
Ametek（AME）与Mirion Technologies, Inc.（MIR）财务数据对比。点击上方公司名可切换其他公司
Ametek的季度营收约是Mirion Technologies, Inc.的7.2倍（$2.0B vs $277.4M）。Ametek净利率更高（19.9% vs 6.2%，领先13.7%）。Ametek同比增速更快（13.4% vs 9.1%）。Ametek自由现金流更多（$527.3M vs $63.2M）。过去两年Mirion Technologies, Inc.的营收复合增速更高（20.0% vs 7.3%）
AMETEK Inc.是美国跨国综合企业，为全球知名的电子仪器及机电设备设计商与制造商，总部位于美国，在全球范围内设有超过150个运营站点，业务覆盖多个国家和地区，为各行业客户提供高性能的相关产品及配套解决方案。
Mirion Technologies是全球领先的辐射检测、监测与安全解决方案提供商，核心产品涵盖个人剂量测量系统、辐射成像设备及辐射风险管理软件，服务核电、医疗、国防、工业等多个核心领域，客户遍布北美、欧洲及亚太地区。
AME vs MIR — 直观对比
营收规模更大
AME
是对方的7.2倍
$277.4M
营收增速更快
AME
高出4.4%
9.1%
净利率更高
AME
高出13.7%
6.2%
自由现金流更多
AME
多$464.1M
$63.2M
两年增速更快
MIR
近两年复合增速
7.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $277.4M |
| 净利润 | $398.6M | $17.3M |
| 毛利率 | 36.0% | 48.8% |
| 营业利润率 | 25.3% | 9.2% |
| 净利率 | 19.9% | 6.2% |
| 营收同比 | 13.4% | 9.1% |
| 净利润同比 | 2.9% | 15.3% |
| 每股收益（稀释后） | $1.73 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMEMIR
| Q4 25 | $2.0B | $277.4M | ||
| Q3 25 | $1.9B | $223.1M | ||
| Q2 25 | $1.8B | $222.9M | ||
| Q1 25 | $1.7B | $202.0M | ||
| Q4 24 | $1.8B | $254.3M | ||
| Q3 24 | $1.7B | $206.8M | ||
| Q2 24 | $1.7B | $207.1M | ||
| Q1 24 | $1.7B | $192.6M |
净利润AMEMIR
| Q4 25 | $398.6M | $17.3M | ||
| Q3 25 | $371.4M | $2.9M | ||
| Q2 25 | $358.4M | $8.3M | ||
| Q1 25 | $351.8M | $300.0K | ||
| Q4 24 | $387.3M | $15.0M | ||
| Q3 24 | $340.2M | $-13.6M | ||
| Q2 24 | $337.7M | $-11.7M | ||
| Q1 24 | $310.9M | $-25.8M |
毛利率AMEMIR
| Q4 25 | 36.0% | 48.8% | ||
| Q3 25 | 36.3% | 46.8% | ||
| Q2 25 | 35.8% | 46.0% | ||
| Q1 25 | 36.1% | 47.6% | ||
| Q4 24 | 36.6% | 48.1% | ||
| Q3 24 | 36.0% | 44.9% | ||
| Q2 24 | 36.0% | 47.0% | ||
| Q1 24 | 34.1% | 45.2% |
营业利润率AMEMIR
| Q4 25 | 25.3% | 9.2% | ||
| Q3 25 | 25.8% | 3.3% | ||
| Q2 25 | 26.0% | 4.4% | ||
| Q1 25 | 26.3% | 4.3% | ||
| Q4 24 | 26.6% | 11.4% | ||
| Q3 24 | 26.1% | -0.8% | ||
| Q2 24 | 25.8% | 1.1% | ||
| Q1 24 | 24.0% | -2.5% |
净利率AMEMIR
| Q4 25 | 19.9% | 6.2% | ||
| Q3 25 | 19.6% | 1.3% | ||
| Q2 25 | 20.2% | 3.7% | ||
| Q1 25 | 20.3% | 0.1% | ||
| Q4 24 | 22.0% | 5.9% | ||
| Q3 24 | 19.9% | -6.6% | ||
| Q2 24 | 19.5% | -5.6% | ||
| Q1 24 | 17.9% | -13.4% |
每股收益（稀释后）AMEMIR
| Q4 25 | $1.73 | $0.07 | ||
| Q3 25 | $1.60 | $0.01 | ||
| Q2 25 | $1.55 | $0.03 | ||
| Q1 25 | $1.52 | $0.00 | ||
| Q4 24 | $1.67 | $0.08 | ||
| Q3 24 | $1.47 | $-0.07 | ||
| Q2 24 | $1.45 | $-0.06 | ||
| Q1 24 | $1.34 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $458.0M | $412.3M |
| 总债务越低越好 | $2.3B | — |
| 股东权益账面价值 | $10.6B | $1.9B |
| 总资产 | $16.1B | $3.6B |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资AMEMIR
| Q4 25 | $458.0M | $412.3M | ||
| Q3 25 | $439.2M | $933.2M | ||
| Q2 25 | $619.7M | $262.6M | ||
| Q1 25 | $399.0M | $185.8M | ||
| Q4 24 | $374.0M | $175.2M | ||
| Q3 24 | $396.3M | $133.3M | ||
| Q2 24 | $396.6M | $122.2M | ||
| Q1 24 | $373.8M | $120.2M |
总债务AMEMIR
| Q4 25 | $2.3B | — | ||
| Q3 25 | — | $444.8M | ||
| Q2 25 | — | $444.9M | ||
| Q1 25 | — | $686.6M | ||
| Q4 24 | $2.1B | $686.4M | ||
| Q3 24 | — | $685.1M | ||
| Q2 24 | — | $684.1M | ||
| Q1 24 | — | $685.5M |
股东权益AMEMIR
| Q4 25 | $10.6B | $1.9B | ||
| Q3 25 | $10.5B | $1.8B | ||
| Q2 25 | $10.4B | $1.5B | ||
| Q1 25 | $10.0B | $1.5B | ||
| Q4 24 | $9.7B | $1.5B | ||
| Q3 24 | $9.6B | $1.5B | ||
| Q2 24 | $9.3B | $1.5B | ||
| Q1 24 | $9.0B | $1.5B |
总资产AMEMIR
| Q4 25 | $16.1B | $3.6B | ||
| Q3 25 | $16.2B | $3.5B | ||
| Q2 25 | $15.3B | $2.7B | ||
| Q1 25 | $14.9B | $2.6B | ||
| Q4 24 | $14.6B | $2.6B | ||
| Q3 24 | $14.8B | $2.7B | ||
| Q2 24 | $14.8B | $2.6B | ||
| Q1 24 | $14.9B | $2.6B |
负债/权益比AMEMIR
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | 0.22× | 0.46× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.45× | ||
| Q1 24 | — | 0.47× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $584.3M | $73.0M |
| 自由现金流经营现金流 - 资本支出 | $527.3M | $63.2M |
| 自由现金流率自由现金流/营收 | 26.4% | 22.8% |
| 资本支出强度资本支出/营收 | 2.9% | 3.5% |
| 现金转化率经营现金流/净利润 | 1.47× | 4.22× |
| 过去12个月自由现金流最近4个季度 | $1.7B | $106.9M |
8季度趋势，按日历期对齐
经营现金流AMEMIR
| Q4 25 | $584.3M | $73.0M | ||
| Q3 25 | $440.9M | $22.3M | ||
| Q2 25 | $359.1M | $12.4M | ||
| Q1 25 | $417.5M | $35.6M | ||
| Q4 24 | $550.0M | $60.8M | ||
| Q3 24 | $487.2M | $17.1M | ||
| Q2 24 | $381.4M | $15.2M | ||
| Q1 24 | $410.2M | $6.0M |
自由现金流AMEMIR
| Q4 25 | $527.3M | $63.2M | ||
| Q3 25 | $420.0M | $13.0M | ||
| Q2 25 | $329.8M | $3.6M | ||
| Q1 25 | $394.5M | $27.1M | ||
| Q4 24 | $498.3M | $49.1M | ||
| Q3 24 | $460.9M | $3.9M | ||
| Q2 24 | $360.0M | $4.1M | ||
| Q1 24 | $382.6M | $-6.8M |
自由现金流率AMEMIR
| Q4 25 | 26.4% | 22.8% | ||
| Q3 25 | 22.2% | 5.8% | ||
| Q2 25 | 18.5% | 1.6% | ||
| Q1 25 | 22.8% | 13.4% | ||
| Q4 24 | 28.3% | 19.3% | ||
| Q3 24 | 27.0% | 1.9% | ||
| Q2 24 | 20.8% | 2.0% | ||
| Q1 24 | 22.0% | -3.5% |
资本支出强度AMEMIR
| Q4 25 | 2.9% | 3.5% | ||
| Q3 25 | 1.1% | 4.2% | ||
| Q2 25 | 1.6% | 3.9% | ||
| Q1 25 | 1.3% | 4.2% | ||
| Q4 24 | 2.9% | 4.6% | ||
| Q3 24 | 1.5% | 6.4% | ||
| Q2 24 | 1.2% | 5.4% | ||
| Q1 24 | 1.6% | 6.6% |
现金转化率AMEMIR
| Q4 25 | 1.47× | 4.22× | ||
| Q3 25 | 1.19× | 7.69× | ||
| Q2 25 | 1.00× | 1.49× | ||
| Q1 25 | 1.19× | 118.67× | ||
| Q4 24 | 1.42× | 4.05× | ||
| Q3 24 | 1.43× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AME
| Transferred At Point In Time | $1.1B | 54% |
| Electronic Instruments Group | $620.1M | 31% |
| Transferred Over Time | $294.6M | 15% |
MIR
| Transferred Over Time | $96.6M | 35% |
| Services | $65.0M | 23% |
| Cancer Care | $61.8M | 22% |
| Labs And Research | $34.0M | 12% |
| Other Care | $20.7M | 7% |
